Naren L. Banik

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Immunology, Neuroscience Biology, Pharmacology
Google:
"Naren Banik"
Mean distance: 21373.2
 

Children

Sign in to add trainee
Kurt E. Schaecher grad student 2001 MUSC
Eric A. Sribnick grad student 2005 MUSC
Mary K. Guyton grad student 2009 MUSC
Nicole N. Trager grad student 2013 MUSC
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

McCoy HM, Polcyn R, Banik NL, et al. (2023) Regulation of enolase activation to promote neural protection and regeneration in spinal cord injury. Neural Regeneration Research. 18: 1457-1462
Myatich A, Haque A, Sole C, et al. (2022) Clemastine in remyelination and protection of neurons and skeletal muscle after spinal cord injury. Neural Regeneration Research. 18: 940-946
Haque A, Das A, Samantaray S, et al. (2022) Premarin Reduces Neurodegeneration and Promotes Improvement of Function in an Animal Model of Spinal Cord Injury. International Journal of Molecular Sciences. 23
Samantaray S, Knaryan VH, M Del Re A, et al. (2020) Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP. Neurotoxicity Research
Cox A, Capone M, Matzelle D, et al. (2020) Nanoparticle based estrogen delivery to spinal cord injury site reduces local parenchymal destruction and improves functional recovery. Journal of Neurotrauma
Polcyn R, Capone M, Matzelle D, et al. (2020) Enolase inhibition alters metabolic hormones and inflammatory factors to promote neuroprotection in spinal cord injury. Neurochemistry International. 104788
Haque A, Samantaray S, Knaryan VH, et al. (2020) Calpain mediated expansion of CD4+ cytotoxic T cells in rodent models of Parkinson's disease. Experimental Neurology. 113315
Polcyn R, Capone M, Matzelle D, et al. (2019) Cytokine/chemokine dysregulation in progressive MS patient is apparent and can be modulated by calpain inhibition. Metabolic Brain Disease
Shams R, Banik NL, Haque A. (2019) Calpain in the cleavage of alpha-synuclein and the pathogenesis of Parkinson's disease. Progress in Molecular Biology and Translational Science. 167: 107-124
Chandran R, Capone M, Matzelle D, et al. (2018) Distinct Cytokine and Chemokine Expression in Plasma and Calpeptin-Treated PBMCs of a Relapsing-Remitting Multiple Sclerosis Patient: A Case Report. Neurochemical Research
See more...